Hester Biosciences Limited — Important, 28-10-2024: Financial Result Updates

Hester Biosciences reported strong financial results for Q2 and H1 FY25, with standalone revenue growth of 12% and 24%, respectively. Consolidated results showed a significant 21% increase in product sales and a remarkable 108% rise in profit. The Animal Healthcare division saw a 4% growth in Q2, while Poultry Healthcare surged by 20%. Profit after tax was up 38% at ₹93.36 million. Hester continues to innovate and expand its product offerings across all sectors.